Eva Tolosa

Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.

The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo.

Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus.

Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.

Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells.

Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules.

Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro.

HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.

Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response.

Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.

Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.

Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels.

Cathepsin G is differentially expressed in primary human antigen-presenting cells.

Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs.

Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.

Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

United Europeans for development of pharmacogenomics in multiple sclerosis network.

Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.

Antigen processing and presentation in multiple sclerosis.

Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression.

Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.

Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.

The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice.

Cathepsin S dominates autoantigen processing in human thymic dendritic cells.

Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke.

Relapsing cerebral aspergilloma associated with pregnancy.

Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.

Exploring the MHC-peptide matrix of central tolerance in the human thymus.

Effect of prenatal steroid treatment on the developing immune system.